These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 12889719)

  • 1. Cumulative irritation comparison of adapalene gel and solution with 2 tazarotene gels and 3 tretinoin formulations.
    Greenspan A; Loesche C; Vendetti N; Georgeian K; Gilbert R; Poncet M; Baker MD; Soto P
    Cutis; 2003 Jul; 72(1):76-81. PubMed ID: 12889719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cumulative irritancy potential of adapalene cream 0.1% compared with adapalene gel 0.1% and several tretinoin formulations.
    Brand B; Gilbert R; Baker MD; Poncet M; Greenspan A; Georgeian K; Soto P
    Cutis; 2003 Dec; 72(6):455-8. PubMed ID: 14700217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the cumulative irritation potential of adapalene gel and cream with that of erythromycin/tretinoin solution and gel and erythromycin/isotretinoin gel.
    Queille-Roussel C; Poncet M; Mesaros S; Clucas A; Baker M; Soloff AM
    Clin Ther; 2001 Feb; 23(2):205-12. PubMed ID: 11293554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tazarotene cream 0.05% and 0.1%.
    Dosik JS; Homer K; Arsonnaud S
    Cutis; 2005 May; 75(5):289-93. PubMed ID: 15984630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cumulative irritation potential of adapalene 0.1% cream and gel compared with tretinoin microsphere 0.04% and 0.1%.
    Dosik JS; Homer K; Arsonnaud S
    Cutis; 2005 Apr; 75(4):238-43. PubMed ID: 15916222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cumulative irritancy comparison of topical retinoid and antimicrobial combination therapies.
    Dosik JS; Gilbert RD; Arsonnaud S
    Skinmed; 2006; 5(5):219-23. PubMed ID: 16957432
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adapalene gel 0.1% is better tolerated than tretinoin gel 0.025% among healthy volunteers of various ethnic origins.
    Goh CL; Tang MB; Briantais P; Kaoukhov A; Soto P
    J Dermatolog Treat; 2009; 20(5):282-8. PubMed ID: 19634042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and tolerability of adapalene 0.3% gel compared to tazarotene 0.1% gel in the treatment of acne vulgaris.
    Thiboutot D; Arsonnaud S; Soto P
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s3-10. PubMed ID: 18575220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adapalene 0.1% gel compared to tazarotene 0.1% cream in the treatment of acne vulgaris.
    Pariser D; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s18-23. PubMed ID: 18575222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tolerability comparison of adapalene gel, 0.3% versus tazarotene cream, 0.05% in subjects with healthy skin.
    Dosik JS; Arsonnaud S
    J Drugs Dermatol; 2007 Jun; 6(6):632-8. PubMed ID: 17668529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is switching retinoids a sound strategy for the treatment of acne vulgaris?
    Gold LS; Colón LE; Johnson LA; Gottschalk RW
    J Drugs Dermatol; 2008 Jun; 7(6 Suppl):s11-7. PubMed ID: 18575221
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations.
    Galvin SA; Gilbert R; Baker M; Guibal F; Tuley MR
    Br J Dermatol; 1998 Oct; 139 Suppl 52():34-40. PubMed ID: 9990419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, double-blind, randomized comparison study of the efficacy and tolerability of once-daily tazarotene 0.1% gel and adapalene 0.1% gel for the treatment of facial acne vulgaris.
    Webster GF; Guenther L; Poulin YP; Solomon BA; Loven K; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):4-11. PubMed ID: 12095066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized comparison of the safety and efficacy of tazarotene 0.1% cream and adapalene 0.3% gel in the treatment of patients with at least moderate facial acne vulgaris.
    Tanghetti E; Dhawan S; Green L; Del Rosso J; Draelos Z; Leyden J; Shalita A; Glaser DA; Grimes P; Webster G; Barnett P; Le Gall N
    J Drugs Dermatol; 2010 May; 9(5):549-58. PubMed ID: 20480800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris.
    Kakita L
    J Am Acad Dermatol; 2000 Aug; 43(2 Pt 3):S51-4. PubMed ID: 10898831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cumulative irritation potential of topical retinoid formulations.
    Leyden JJ; Grossman R; Nighland M
    J Drugs Dermatol; 2008 Aug; 7(8 Suppl):s14-8. PubMed ID: 18724650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tolerability of clindamycin/tretinoin gel vs. tretinoin microsphere gel and adapalene gel.
    Leyden J; Wortzman M; Baldwin EK
    J Drugs Dermatol; 2009 Apr; 8(4):383-8. PubMed ID: 19363857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Once-daily tazarotene 0.1 % gel versus once-daily tretinoin 0.1 % microsponge gel for the treatment of facial acne vulgaris: a double-blind randomized trial.
    Leyden JJ; Tanghetti EA; Miller B; Ung M; Berson D; Lee J
    Cutis; 2002 Feb; 69(2 Suppl):12-9. PubMed ID: 12095064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spotlight on adapalene in acne vulgaris.
    Waugh J; Noble S; Scott LJ
    Am J Clin Dermatol; 2004; 5(5):369-71. PubMed ID: 15554742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Irritation potential of tretinoin gel microsphere pump versus adapalene plus benzoyl peroxide gel.
    Leyden JJ; Nighland M; Rossi AB; Ramaswamy R
    J Drugs Dermatol; 2010 Aug; 9(8):998-1003. PubMed ID: 20684151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.